125472 [2027]

This is the Biologics License Application (BLA) number for Actemra (tocilizumab) . Specifically, it covers the subcutaneous injection formulation used to treat conditions like moderate to severe Rheumatoid Arthritis .

The number primarily refers to several official documents and technical posts, most notably in the fields of pharmaceutical regulation and web development: 125472

Filing #125472 relates to a USPS response to a Chairman's Information Request under seal, filed in June 2023. Filing 125472 - Postal Regulatory Commission - ArkCase This is the Biologics License Application (BLA) number